Indian pharmaceutical firm Gennova Biopharmaceuticals` COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday (August 24).

Government authorities have also approved further studies to test the vaccine`s efficacy in a larger population. Gennova plans to conduct a mid-stage study at about 10 to 15 sites and a late-stage trial at 22 to 27 sites in India.

Leave a Reply

Your email address will not be published. Required fields are marked *